This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Maguire Properties, Compugen: Midday Volume Plays

NEW YORK ( TheStreet) -- Maguire Properties (MPG) was one of several stocks trading near $5 were moving on above-average volume Tuesday.

Maguire Properties said its first-quarter funds from operations, or FFO, was $35.6 million, or 72 cents a share, compared with a year-ago loss of $30.8 million, or 64 cents a share. On an adjusted basis, Maguire Properties said it had FFO of 5 cents a share, above the Thomson Reuters average estimate for earnings of 3 cents a share.

Early Tuesday, Maguire Properties said it has changed its name to MPG Office Trust effective immediately, and it will begin trading under the new name on May 17.

Shares of Maguire Properties jumped by 33 cents, or 10.5%, to $3.47. Volume topped 2.32 million shares, compared to the three-month average daily volume of 3.16 million, according to Yahoo! Finance.

Elsewhere, ADDvantage Technologies Group (AEY - Get Report) rallied by 70 cents, or 27.3%, to $3.26 after the cable television electronics company said second-quarter net income rose to 11 cents a share from 7 cents a share in the year-ago quarter. Revenue climbed 19% to $12.1 million, ADDvantage said. Volume topped 128,000 shares, compared to the three-month average daily volume of 13,000.

Response Genetics (RGDX - Get Report) surged by 73 cents, or 33.8%, to $2.88 after the company said it has signed an agreement with GlaxoSmithKline (GSK) to provide proprietary BRAF mutational analysis technology to assess BRAF gene mutations in human tumor samples. Volume topped 179,000 shares, compared to the 50-day average daily volume of 20,000, according to the Nasdaq.

Compugen (CGEN - Get Report) rose by 32 cents, or 7.3%, to $4.73 after the company announced the discovery and initial experimental validation of CGEN-928 as a drug target for the treatment of multiple myeloma. Volume topped 98,000 shares, compared to the 50-day average daily volume of 207,000.

-- Written by Robert Holmes in Boston.

Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
MPG $19.90 1.74%
AEY $2.42 1.26%
CGEN $8.36 -2.90%
RGDX $0.62 -6.53%
AAPL $128.46 -1.50%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs